Revenue
0 USD
2014 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Market value is not computed: no recent price is available.
109 filing records in this dataset, filed from 1996-05-15 to 2022-04-14. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
0 USD
2014 Q3 · USD
-722 thousand USD
2014 Q3 · USD
-722 thousand USD
2014 Q3 · USD
386027 USD
40330117 shares
178.34% · 25.8 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
0 USD
2013-10-01 – 2014-09-30
-518 thousand USD
2020-01-01 – 2020-12-31
-1.13 million USD
2020-01-01 – 2020-12-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2022-04-14.
Financial data available through: 2020-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 866,675
–
Current period
−USD 517,897
–
-517897 − 866675 = -1384572 USD
866675 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source-517897 USD · 2020-01-01 – 2020-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 137,162
–
Current period
−USD 1.13 million
–
-1133005 − -137162 = -995843 USD
-137162 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source-1133005 USD · 2020-01-01 – 2020-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2011 2011-01-01 – 2011-12-31 | 0 | 7417917 Derived | -7417917 | -288825 Derived | -7129092 | -7677904 Derived | Source
|
| 2012 2012-01-01 – 2012-12-31 | 59409 | 8353230 Derived | -8293821 | 29489 Derived | -8323310 | -9228431 Derived | Source
|
| 2013 2013-01-01 – 2013-12-31 | 109200 | 7015449 Derived | -6906249 | 2008044 Derived | -8914293 | 5976947 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2011 | Revenue | 0 |
|
| 2012 | Revenue | 59409 |
|
| 2013 | Revenue | 109200 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Year over year | No prior comparable period |
|
| 2012 | Year over year | No prior comparable period |
|
| 2013 | Year over year | 83.8% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Operating margin | Not reported |
|
| 2012 | Operating margin | -13,960.5% |
|
| 2013 | Operating margin | -6,324.4% |
|
| 2011 | Net margin | Not reported |
|
| 2012 | Net margin | -14,010.2% |
|
| 2013 | Net margin | -8,163.3% |
|
| 2011 | Free cash flow margin | Not reported |
|
| 2012 | Free cash flow margin | -15,533.7% |
|
| 2013 | Free cash flow margin | 5,473.4% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2011 | Operating cash flow | -7673496 |
|
| 2012 | Operating cash flow | -9212565 |
|
| 2013 | Operating cash flow | 6000000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2011 | Free cash flow | -7677904 |
|
| 2012 | Free cash flow | -9228431 |
|
| 2013 | Free cash flow | 5976947 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Liabilities / assets | 18.9% |
|
| 2012 | Liabilities / assets | 18.5% |
|
| 2013 | Liabilities / assets | 57.5% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2011 | Current assets / current liabilities | 4.13× |
|
| 2012 | Current assets / current liabilities | 3.08× |
|
| 2013 | Current assets / current liabilities | 0.31× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2011 2011-01-01 – 2011-12-31 | −USD 7.13 million Exact valueExact value: -7129092 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.67 million Exact valueExact value: -7673496 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,408 Exact valueExact value: 4408 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.68 million Calculation and evidence-7673496 − 4408 USD Exact free cash flow: -7677904 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2012 2012-01-01 – 2012-12-31 | −USD 8.32 million Exact valueExact value: -8323310 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.21 million Exact valueExact value: -9212565 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 15,866 Exact valueExact value: 15866 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.23 million Calculation and evidence-9212565 − 15866 USD Exact free cash flow: -9228431 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2013 2013-01-01 – 2013-12-31 | −USD 8.91 million Exact valueExact value: -8914293 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6 million Exact valueExact value: 6000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 23,053 Exact valueExact value: 23053 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.98 million Calculation and evidence6000000 − 23053 USD Exact free cash flow: 5976947 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2014 2014-01-01 – 2014-12-31 | −USD 5.51 million Exact valueExact value: -5505536 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.62 million Exact valueExact value: -2624113 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2015-01-01 – 2015-12-31 | −USD 3.7 million Exact valueExact value: -3697560 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.05 million Exact valueExact value: -1052895 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2016-01-01 – 2016-12-31 | −USD 2.92 million Exact valueExact value: -2918228 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.02 million Exact valueExact value: -2023607 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 171,728 Exact valueExact value: 171728 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.2 million Calculation and evidence-2023607 − 171728 USD Exact free cash flow: -2195335 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 1.89 million Exact valueExact value: -1894142 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.06 million Exact valueExact value: -1062388 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 434,881 Exact valueExact value: -434881 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 451,503 Exact valueExact value: -451503 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | USD 866,675 Exact valueExact value: 866675 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 137,162 Exact valueExact value: -137162 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 517,897 Exact valueExact value: -517897 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.13 million Exact valueExact value: -1133005 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,433 Exact valueExact value: 3433 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.14 million Calculation and evidence-1133005 − 3433 USD Exact free cash flow: -1136438 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
109 filings · 2,058 latest values · 2,058 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000772320, 772320, CRXM, edgar:772320
Also known as ARIES VENTURES INC, CASMYN CORP, Cardium Therapeutics, Inc., Gene Biotherapeutics, Inc., Taxus Cardium Pharmaceuticals Group Inc.